retatrutide side effects clinical trial results 2024 2025 More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Eli Lilly's Weight Loss Superdrug

Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke

In case of noise exposure of 8 hours per day, it declines significantly as compared to noise exposure of 4 hours per day

I am not sure what the cause is for that

GLP-1 medications offer meaningful health benefits, but this survey highlights trends related to cost and insurance coverage that introduce uncertainty for a patients ability to access these drugs, said Sharon Faust, Chief Pharmacy Officer at Navitus Health Solutions

Research highlights include: Long-Term Efficacy : Studies indicate that GLP-1 medications remain effective for weight loss over extended periods, with sustained reductions in body weight and improvements in glycemic control

271,272 In one randomized controlled trial, 84 postmenopausal women experiencing at least two moderate-to-severe hot flashes daily were assigned to eat a low-fat vegan diet (that included cooked soybeans) or make no dietary change